Principal Financial Group Inc. bought a new position in shares of National Research Co. (NASDAQ:NRC – Free Report) during the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund bought 10,857 shares of the company’s stock, valued at approximately $248,000.
Other large investors have also recently made changes to their positions in the company. Quarry LP purchased a new stake in National Research in the second quarter valued at approximately $54,000. Benjamin F. Edwards & Company Inc. raised its position in National Research by 145.6% in the 2nd quarter. Benjamin F. Edwards & Company Inc. now owns 2,783 shares of the company’s stock valued at $64,000 after purchasing an additional 1,650 shares during the last quarter. FMR LLC raised its position in National Research by 397.3% in the 3rd quarter. FMR LLC now owns 2,944 shares of the company’s stock valued at $67,000 after purchasing an additional 2,352 shares during the last quarter. Gladius Capital Management LP boosted its stake in National Research by 164.5% during the 3rd quarter. Gladius Capital Management LP now owns 3,068 shares of the company’s stock worth $70,000 after purchasing an additional 1,908 shares during the period. Finally, Point72 Asset Management L.P. acquired a new position in National Research in the third quarter valued at $88,000. 47.26% of the stock is owned by institutional investors and hedge funds.
National Research Price Performance
Shares of NASDAQ:NRC opened at $17.67 on Tuesday. National Research Co. has a one year low of $16.74 and a one year high of $42.00. The stock has a market capitalization of $414.82 million, a price-to-earnings ratio of 15.64 and a beta of 0.53. The company has a 50-day simple moving average of $18.68 and a 200-day simple moving average of $20.82. The company has a debt-to-equity ratio of 1.30, a quick ratio of 0.47 and a current ratio of 0.47.
National Research Dividend Announcement
The company also recently disclosed a quarterly dividend, which will be paid on Friday, January 10th. Investors of record on Friday, December 27th will be given a $0.12 dividend. The ex-dividend date is Friday, December 27th. This represents a $0.48 dividend on an annualized basis and a yield of 2.72%. National Research’s dividend payout ratio (DPR) is 42.48%.
About National Research
National Research Corporation provides analytics and insights that facilitate measurement and enhancement of the patient and employee experience. Its portfolio of subscription-based solutions provides actionable information and analysis to healthcare organizations across a range of mission-critical, constituent-related elements, including patient experience, service recovery, care transitions, employee engagement, reputation management, and brand loyalty.
Featured Stories
- Five stocks we like better than National Research
- Why Special Dividends Can be a Delightful Surprise for Income Investors
- Build-Your-Bowl Battle: CAVA, Chipotle, and Sweetgreen Face Off
- The Significance of a Trillion-Dollar Market Cap Goes Beyond a Number
- Insiders Are Loading Up: 3 Key Stock Picks for Investors
- Are These Liquid Natural Gas Stocks Ready For An Upside Bounce?
- How Cigna Remains at the Top of the Health Insurance Food Chain
Want to see what other hedge funds are holding NRC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for National Research Co. (NASDAQ:NRC – Free Report).
Receive News & Ratings for National Research Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for National Research and related companies with MarketBeat.com's FREE daily email newsletter.